Visual and Refractive Outcomes of a New Diffractive Trifocal Toric Intraocular Lens — RibeiroPODFT  

Cataract Clinical Trial

Official title: Visual and Refractive Outcomes of a New Diffractive Trifocal Toric Intraocular Lens

Status Completed

Clinical Trial Summary

The purpose of this study is to investigate the visual performance and refractive predictability with the diffractive toric Finevision POD FT IOL. Predicted and achieved visual outcomes, visual performance at near, intermediate and far distance as well as photic phenomena, rotational stability and spectacle independence will be investigated. The follow-up period is 3 months after which vision and refraction should have stabilized.

Clinical Trial Description

This prospective study was performed to investigate the visual performance and refractive predictability with the diffractive toric Finevision POD FT IOL (PhyslOL, Belgium). Predicted and achieved visual outcomes, visual performance at near, intermediate and far distance as well as rotational stability have been analyzed. The follow-up period was 6 months. All IOL implantations were performed by the investigators Dr. Filomena Ribeiro and Dr. Tiago B Ferreira (Hospital da Luz, Lisboa, Portugal). The study population consists of patients undergoing routine cataract surgery. The study patients underwent binocular implantation of Finevision IOLs depending on the preoperative amount of corneal astigmatism (either a toric POD FT IOL in both eyes or a POD FT in the study eye and a non-toric POD F IOL in the contralateral eye). ;

Related Conditions & MeSH terms

• Cataract

• NCT number: NCT04940793
• Study type: Observational
• Source: Beaver-Visitec International, Inc.
• Status: Completed
• Start date: July 18, 2017
• Completion date: January 23, 2019